Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
E
enGene Therapeutics Inc
NASDAQ:ENGN
enGene Therapeutics Inc
NASDAQ:ENGN
Price:
1.53
USD
Market Closed
Market Cap:
$102.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
enGene Therapeutics Inc
NASDAQ:ENGN
|
CA |
|
N
|
Nonthavej Hospital PCL
SET:NTV
|
TH |
|
Gap Inc
NYSE:GAP
|
US |
|
S
|
Square Enix Holdings Co Ltd
F:EI4
|
JP |
|
Avolta AG
OTC:DFRYF
|
CH |
|
C
|
Coeur Mining Inc
DUS:CDM1
|
US |
|
Toyota Motor Corp
NYSE:TM
|
JP |
|
Black Cat Syndicate Ltd
ASX:BC8
|
AU |
Wall St Price Targets
ENGN Price Forecast
Based on 12 analysts
Based on 12 analysts
+167% Upside
from
$1.53
today
enGene Therapeutics Inc (ENGN)’s 12-month stock price forecast through October 2027 has a consensus target of $4.08, implying 167% upside. The forecast is based on price targets from 12 Wall Street analysts.
enGene Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ENGN's stock price target?
Price Target
4.08
USD
4.08
USD
According to Wall Street analysts, the average 1-year price target for ENGN is 4.08 USD with a low forecast of 2.02 USD and a high forecast of 28.35 USD.